Analyst Research

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

CellaVision revises FY 2013 sales outlook


Wednesday, 15 Jan 2014 02:25am EST 

CellaVision AB:Revises FY 2013 financial outlook due to sales increase in Q4 2013 in comparison with the corresponding quarter in 2012.Expects FY 2013 revenue to increase by 5-7 percent in comparison with 2012.Says sales in Q4 2013 will increase by 28-30 percent in comparison to last year.